Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Human immunodeficiency virus (HIV) infection of the central nervous system (CNS) is an early event that can lead to neurological dysfunction.
• Despite antiretroviral therapy, cognitive impairment is increasing in individuals with acquired immunodeficiency syndrome (AIDS) due to incompletely understood mechanisms.
• Current understanding of CNS dysfunction in HIV includes inflammation, viral presence, and replication.

Purpose of the Study:

• To characterize the role of gap junctions in transmitting and amplifying toxic signals from HIV-infected astrocytes.
• To investigate the mechanism by which HIV-infected astrocytes induce cell death in uninfected astrocytes.
• To determine if gap junction blockers can prevent apoptosis in uninfected astrocytes.

Main Methods:

• Culture of HIV-infected and uninfected astrocytes.
• Assessment of apoptosis in astrocytes forming gap junctions.
• Treatment with gap junction blockers.

Main Results:

• HIV-infected astrocytes were resistant to apoptosis.
• Uninfected astrocytes forming gap junctions with HIV-infected astrocytes underwent apoptosis.
• Gap junction blockers significantly reduced apoptosis in uninfected astrocytes.

Conclusions:

• Gap junctions play a novel role in amplifying toxic signals from HIV-infected astrocytes, leading to cell death in uninfected astrocytes.
• This gap junction-mediated amplification of toxicity contributes to the pathogenesis of NeuroAIDS.
• Targeting gap junctions may offer a therapeutic strategy for mitigating HIV-associated neurotoxicity.